ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
MedTech Acquisition Corporation

MedTech Acquisition Corporation (MTAC)

11,34
0,00
(0,00%)
Fermé 01 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
11,34
Prix Achat
11,30
Prix Vente
11,94
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
11,34
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
1 953 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,35
Bénéfice par action (BPA)
-32,4
Chiffre d'affairess
18,51M
Bénéfice net
-63,28M

À propos de MedTech Acquisition Corporation

MedTech Acquisition Corp is a blank check company. MedTech Acquisition Corp is a blank check company.

Secteur
Surgical,med Instr,apparatus
Industrie
Blank Checks
Siège social
Wilmington, Delaware, USA
Fondé
2023

MTAC Dernières nouvelles

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of...

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc...

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

TriSalus Life Sciences® Inc., (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with...

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with...

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition...

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company...

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021 HCA Florida Healthcare's Kendall Regional Medical Center, AdventHealth Celebration and The Women's...

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation Industry veterans with leadership experience...

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal PR Newswire OR YEHUDA, Israel, Aug. 19, 2021 OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures...

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination - Memic's Hominis® platform is the first and only FDA-authorized surgical robot that...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MTAC - Frequently Asked Questions (FAQ)

What is the current MedTech Acquisition share price?
The current share price of MedTech Acquisition is US$ 11,34
How many MedTech Acquisition shares are in issue?
MedTech Acquisition has 1 953 000 shares in issue
What is the market cap of MedTech Acquisition?
The market capitalisation of MedTech Acquisition is USD 22,15M
What is the 1 year trading range for MedTech Acquisition share price?
MedTech Acquisition has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of MedTech Acquisition?
The price to earnings ratio of MedTech Acquisition is -0,35
What is the cash to sales ratio of MedTech Acquisition?
The cash to sales ratio of MedTech Acquisition is 1,2
What is the reporting currency for MedTech Acquisition?
MedTech Acquisition reports financial results in USD
What is the latest annual turnover for MedTech Acquisition?
The latest annual turnover of MedTech Acquisition is USD 18,51M
What is the latest annual profit for MedTech Acquisition?
The latest annual profit of MedTech Acquisition is USD -63,28M
What is the registered address of MedTech Acquisition?
The registered address for MedTech Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
Which industry sector does MedTech Acquisition operate in?
MedTech Acquisition operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,58M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,91M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,93k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
900,48k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,42M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,54M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,29M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,8M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock